[Risk factors for heart failure in women: atrial fibrillation]

Area of Science:

• Cardiology
• Electrophysiology
• Internal Medicine

Context:

• Heart failure (HF) patients exhibit a higher prevalence of atrial fibrillation (AF) compared to the general population.
• Women with HF face a greater risk of developing AF and experiencing related complications like thromboembolic events.

Purpose:

• To summarize the complex relationship between atrial fibrillation and heart failure, focusing on epidemiological differences, therapeutic challenges, and clinical outcomes, particularly in women.
• To highlight the increased mortality and thromboembolic risk associated with AF in HF patients.
• To discuss the underuse of oral anticoagulants in HF-AF patients due to bleeding risks and the limitations of rhythm control strategies.

Summary:

• AF in HF patients is linked to increased mortality and thromboembolic events, with women being disproportionately affected.
• The heightened bleeding risk with oral anticoagulants in HF leads to their underuse, especially in women.
• Rate control is often preferred over rhythm control for AF in HF due to increased mortality with antiarrhythmic drugs and lower cardioversion efficacy.

Impact:

• Understanding these dynamics is crucial for optimizing treatment strategies and improving outcomes for heart failure patients with atrial fibrillation.
• The findings underscore the need for careful consideration of anticoagulation and rhythm control approaches in this vulnerable patient population.
• Further research may lead to safer and more effective therapies for managing AF in heart failure, potentially reducing cardiovascular events and mortality.